Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sharon Kleyne and Colleagues Weigh in on Water and Patented Dry Eye Disease Application
  • USA - English


News provided by

Bio-Logic Aqua® Research – Water Life Science® -Rogue Media

Sep 01, 2016, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Grants Pass, OR (PRWEB) September 01, 2016 -- Bio-Logic Aqua® Research Water Life Science® founder Sharon Kleyne recently declared war on Dry Eye Disease, announcing on The Sharon Kleyne Hour Power of Water radio program a new global education campaign. The campaign is ambitiously designed to deliver the facts about Dry Eye Disease and its new water technology treatment to everyone on earth. The new water technology includes a globally patented, personal hand-held humidifier for misting afflicted tear film of the eyes with Trade Secret tissue culture grade water that is painless, fun and effective. This new water lifestyle and its advanced technology already has the endorsements of thousands of medical professionals and scientists around the world.

Dry Eye Disease afflicts millions of people worldwide. In its chronic stage, Dry Eye Disease can develop into severe headaches, glaucoma, cataracts and even blindness. Dry Eye Disease generates hundreds of millions of lost, productive hours in the global workforce every year; it’s a condition that only gets worse as you grow older. But just what is this malady, this Dry Eye Disease, and what can one do about it?

Water advocate Sharon Kleyne, founder of Bio-Logic Aqua® Research Water Life Science®, host of The Sharon Kleyne Hour Power of Water radio program and her colleagues have led the way to greater understanding of Dry Eye Disease and to the development of globally patented, advanced technology in Dry Eye treatment.

So, what is Dry Eye Disease? Dr. William D. Mathers explains: “The lachrymal gland produces growth factors, enzymes, proteins and antibodies that are essential to the health of the ocular surface. When the lachrymal gland fails to bathe the eye in sufficient concentrations of these molecules, the ocular surface is compromised and subject to damage and inflammation, which produces dry eye symptoms.”

Kleyne says that Dry Eye Disease occurs when the eye’s tear film, which is 99 percent water, loses moisture through evaporation of the water vapor, a process that begins at birth and requires that eye moisture be constantly replenished. “No two eyes are alike,” Kleyne reminds us. “Each has its own unique water loss, which must be recycled.”

This water loss, or evaporation, can be caused by stress, diet, contamination of the water vapor due to pollution, global warming, indoor heating and air conditioning. Recent research by the American Academy of Ophthalmology links Dry Eye Disease in women to the onset of menopause. According to the Academy, autoimmune diseases such as lupus and rheumatoid arthritis can also lead to decreased tear secretion and Dry Eye Disease. Academy research also cautions that many medications, both prescription and over-the-counter can cause Dry Eye Disease by reducing natural tear secretion. Medications to watch out for include diuretics for high blood pressure, sleeping pills, pain relievers, anti-anxiety medications, antihistamines for allergies and beta-blockers for heart issues and high blood pressure. Even the chemicals in eye drops, the Academy warns, can bring on Dry Eye Disease or make it worse.

These many causes can discourage sufferers and obscure the best and simplest, globally patented treatment for Dry Eye Disease. Sharon Kleyne and her research team at Bio-Logic Aqua® Research Water Life Science® made a startling discovery in water, then developed advanced technology to deliver the water to the dry eye. “The globally patented application of 100% tissue culture grade water (not lotions, crèmes or chemicals) in an ultra-fine mist is the only way to add pure moisture back to dry eyes and stop Dry Eye Disease in its tracks,” says Kleyne.

Dr. Gerald H. Pollack, Dr. Pollack, Editor-in-Chief of WATER and author of The Fourth Phase of Water, notes that Kleyne and her research center’s procurement of the first water-related patent for the micron mist personal humidifier was a breakthrough in water research and new water technology.

Kleyne says that the research and new technology led to the development and release around the world of Nature’s Tears® EyeMist®, the only product that is Trade Secret tissue culture grade water and the perfect solution to Dry Eye Disease. A hand-held portable personal humidifier, with a globally awarded patent, delivers the water to the eye in the form of a fine micron mist that is painless and fun to use. “Most important, though,” says Kleyne, “is that it works. Dry Eye Disease can’t happen, or persist, as long as the eye’s tear film has adequate moisture.” Because Nature’s Tears® EyeMist® is so effective against Dry Eye Disease, Bio-Logic Aqua® Research Water Life Science® has earned global patents and the enthusiastic endorsements of thousands of optometrists and physicians worldwide. For example, University of Arkansas Ophthalmology Professor Dr. Laurie Barber recommends an all-water tear film supplement, Nature’s Tears® EyeMist®, for treatment of Dry Eye Disease.

“Water Life Science is a major technological, global breakthrough that is drowning Dry Eye Disease in life-sustaining tissue culture grade water,” Kleyne says.

Mikaylah Roggasch, Bio-Logic Aqua® Research – Water Life Science® -Rogue Media, http://www.biologicaqua.com, +1 (800) 367-6478, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.